Abstract
Prostate cancer (PC) is a neoplasia with high global incidence and variable behaviour, whose progression could lead to letal complications. Due to its heterogeneous character, the therapeutic choices depend on the clinical initial presentation. For this matter, the discovery of predictive biomarkers is of significant importance, intending to improve disease prognosis and its treatment. On…